BioPharma

The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...

Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam. It is well to be noted that this agreement was officially concluded at a signing...

Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announces the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. The acquisition is...

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...

LOTTE BIOLOGICS, on September 1, 2025, announced that it has gone on to enter into a late-stage commercial contract manufacturing collaboration along with one of the global biopharmaceutical companies from the US. It is well to be noted that this...

In one of the forward-looking statements published on 14 August 2025, Eli Lilly has reaffirmed its commitment to keeping the country right at the forefront when it comes to biopharmaceutical innovation while advocating for reforms for drug pricing in...

Padcev, which happens to be an antibody drug conjugate that Pfizer has acquired in its $43 billion buyout of Seagen, has gone on to meet the primary objective of a bladder cancer trial, thereby helping people who were ineligible...